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Abstract
Background: Women with diabetes are at increased risk of adverse maternal and fetal outcomes. Preconception care can
improve pregnancy outcomes and is paramount to minimise complications, but, current provision is sub-optimal. Mobile
technology, particularly smartphones and apps have the potential to improve preconception care provision but research is
lacking in this area. The need to use modern technologies to improve preconception care knowledge and awareness led to
the development of a preconception and diabetes information app in Stage A of this study.
Objective: The aim of this paper, Stage B of the study, is to explore the feasibility and acceptability of the Preconception and
Diabetes Information app to improve preconception care knowledge and attitudes in women with diabetes, and explore the
potential for wider implementation.
Methods: A mixed-methods study design adopting a quasi-experimental approach will assess women’s knowledge and
attitudes related to preconception care, and level of patient activation (knowledge and confidence for self-management of
health) before and after the three-month intervention period. A log of activity will be used to determine engagement with
the app and semi-structured interviews will explore women’s experiences.
Conclusions: This is the first study to explore the acceptability and feasibility of a preconception and diabetes information
app for women with diabetes. The app has potential to change the way preconception care is delivered, improve pregnancy
outcomes and be widely implemented both in developed and developing countries. This is important given the considerable
shortfalls in current preconception care services in the United Kingdom and around the world.
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Introduction
Diabetes mellitus (DM) has been deemed a global
emergency.1,2 Worldwide, 415 million adults have
DM and by 2040, this is predicted to rise to 642 million
adults.2 There are two main types of DM that aﬀect
women before pregnancy: Type 1 (the pancreas does
not produce any insulin) and Type 2 (the amount of
insulin produced by the pancreas is insuﬃcient or the
body develops a resistance to insulin produced).1,2 DM
is the most common pre-existing medical condition that
can complicate pregnancy creating considerable risks
both for mother and child.35 Poorly controlled DM
together with unplanned pregnancy increases the risk
of maternal and fetal complications. In addition to the
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increased risk of fetal and maternal death, common
complications include miscarriage, birth defects,
preterm labour and birth injury,36 the risks of which
can be minimised through preconception care (PCC).
This is targeted medical care and advice about preg-
nancy planning which can improve pregnancy out-
comes by increasing knowledge and supporting
women to adopt healthy behaviours, e.g. blood glucose
monitoring and folic acid use before pregnancy.3,5,712
Clinical guidelines recommend that PCC is provided to
all women with DM once they reach adoles-
cence.3,6,13,14 However, evidence suggests that PCC is
hindered by poor implementation of clinical guide-
lines,11,15,16 provider- and patient-level barriers,10,12,16
sub-optimal uptake10,17 and inadequate knowledge of
PCC.8,12 These have negative implications for women
with DM around the world, especially those in develop-
ing countries who are at greatest risk of adverse preg-
nancy outcomes.18
There is therefore a need to adopt more innovative
approaches to delivering PCC. Evidence suggests that
while PCC delivered by multimedia, i.e. compact discs
with read-only memory (CD-ROMs) and digital video
discs (DVDs)1922 is feasible and eﬀective in raising
awareness of PCC in women with DM,12 these multi-
media technologies are now outdated. Consequently
they oﬀer limited scope to the many women without
access to computers or DVD players who increasingly
rely on apps delivered by smartphones to access health
information.23 The smartphone is the most popular
mobile device, with over a billion users worldwide.23
It is technologically advanced, easily accessible,
mobile and oﬀers the opportunity to penetrate a
larger population.23,24 In most developed countries,
smartphones are ingrained into daily life while in
developing economies, usage is proliferating rapidly
and is expected to approach levels seen in developed
countries.24 Most smartphone functionalities are aided
by apps (software designed to run on smartphones),
and in a recent qualitative study, women with DM sug-
gested development of a PCC app to help convey PCC
education, increase knowledge of diabetes and preg-
nancy and improve PCC uptake.8
The increasing availability of health information in
easily accessible digital format is rapidly changing the
health education and information paradigm.25 There is
some evidence to suggest that apps can help improve
women’s knowledge of family planning and contracep-
tion26 and to reduce body mass index (BMI).27 They
have also contributed to healthy behavioural changes in
other areas  medication management, diet control,
physical activity, lifestyle improvement, smoking cessa-
tion and diabetes management.28 The acceptance,
coverage and eﬀectiveness of apps in improving
knowledge and enhancing behaviour change, coupled
with the need for increased PCC awareness and
uptake in women with DM, led to the development of
a Preconception and Diabetes Information (PADI) app
in Stage A of this study. The PADI app is designed to
provide ﬂexible and easy access to information about
PCC, blood glucose monitoring and support for
women with DM to optimise their health from precon-
ception to early pregnancy. This paper presents Stage B
of the study, the primary aim of which is to test the
feasibility and acceptability of the PADI app and
explore its potential for wider implementation.
Methods
Study design
A mixed-methods2931 study design incorporating sev-
eral data-collection methods will be used to explore the
feasibility of the PADI app for women with Type 1 DM
(T1DM) and Type 2 DM (T2DM). A longitudinal
quasi-experimental approach with two data collection
points, at the beginning and end of three months of app
usage (Figure 1), will be used to assess women’s know-
ledge and attitudes to PCC. The quasi-experiment will
not involve an external control group, outcomes will be
measured before participants receive the intervention
and again after the intervention, and any changes in
measurement compared within the individuals over a
period of time to determine the impact of the interven-
tion.32,33 A log of activity will be used to determine
engagement with the app, a simple visual scale will
measure satisfaction and semi-structured interviews
will explore women’s experiences of app usage.
Conceptual framework
The Normalisation Process Theory (NPT)34 provides the
theoretical basis for this study. The NPT provides a
framework that is useful for assessing and enhancing
the implementation potential of technological interven-
tions. It addresses the factors for successful implementa-
tion and integration of health interventions into routine
practice, a process known as normalisation. The four
components of the NPT (Table 1) were considered
before and during the development of the app, and
incorporated into the design of this feasibility study.
Ethical review
Favourable ethical opinion was obtained from United
Kingdom National Research Ethics Service (UK
NRES) Committee East Midlands-Derby; REC refer-
ence 15/EM/0358; IRAS project ID: 178530.
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Figure 1. Study flow diagram.
Table 1. Components of the Normalisation Process Theory.
Component Related Questions
1. Coherence or sense-making (the meaning the intervention
makes to participants)
Is the intervention easy to understand and what benefits will it bring and to
whom?
2. Cognitive participation or engagement (commitment made by
participants)
Will the target user groups see it as a good idea and will they be prepared to
invest time, energy and work into it?
3. Collective action (effort invested in the intervention by
participants)
How will the intervention affect the work of user groups, will it promote or
impede their work, and what effect will it have on health services, e.g.
consultation time?
4. Reflexive monitoring (appraisal of the intervention by
participants)
How will users perceive use of the intervention, can users contribute feed-
back about the intervention, and is there room for the intervention to be
improved following user experience?
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Recruitment
Participants will be recruited from two National Health
Service (NHS) hospitals in the South of England and via
social media (i.e. Twitter). Eligible participants who
attend the outpatient clinics at the hospitals will be
approached by a member of the healthcare team when
they come for their clinic appointments and asked if they
are willing to speak to a researcher (CHN) about testing
the PADI app. A Twitter advert will be sent out inviting
eligible participants to contact the study researcher if
they are interested in taking part in the study. If partici-
pants indicate interest, they will be asked to provide the
researcher (CHN) with their contact details. Potentially
eligible participants will receive an introduction to the
study face to face, by mail or telephone. It will be made
clear in all information provided to participants that
they do not have to participate in the study and that
they can withdraw from the study at any time without
prejudicing their care. All potentially eligible participants
will be screened for eligibility against the following inclu-
sion criteria:
. Woman of reproductive age (1845 years) with
T1DM or T2DM.
. Diagnosis of diabetes by a healthcare professional
for more than six months.
. Currently are not pregnant, but are planning a
future pregnancy (in the next ﬁve years) or want
children sometime in the future.
. Own a smartphone (iOS or Android).
Those who meet the inclusion criteria will be provided
with a written participant information sheet (PIS)
informing them about the study. They will be given
the opportunity to ask questions and written consent
to participate in the study will be obtained prior to
study commencement. Only eligible participants who
provide written informed consent will be enrolled in
the study.
Sample
A purposive sample of patients with T1DM and T2DM
will be recruited into the study, from two NHS hos-
pitals in the South of England and via social media.
For feasibility studies, a sample size of 12 is considered
suﬃcient.35 Participants for the intervention phase will
comprise (n¼ 1520) women with DM, with attrition
(or drop-outs) estimated at 20%.36 Figure 1 provides a
ﬂowchart of participants through the study.
Intervention
All eligible participants enrolled in the study will
receive the intervention. It is anticipated that
participants will utilise the PADI app for at least ﬁve
minutes a day, 35 minutes a week and seven hours over
three months to (1) access preconception information
and (2) record their blood glucose level.
PADI app development
A co-design approach was used to develop the PADI
app (Figure 2) to help ensure that it met the needs of
women and that its content was appropriate and
acceptable.3740 The PADI development team included
women with DM (app development working group),
healthcare professionals (expert advisory group) and a
digital agency (Netsells Ltd).
Content development. The PADI app content was based
on a series of focus groups and interviews with the
expert advisory group and app development working
group, the majority of whose members were supportive
of using technology to support PCC. The app content
was also informed by previous research in this area
(Holmes et al.21) and the ﬁndings from a recent sys-
tematic review.10
Expert advisory group
The expert advisory group comprised doctors (general
practitioner, obstetrician, endocrinologist) and nurses
(research and specialist) who suggested including the
following information: importance of planning preg-
nancy and using contraception until stable HbA1c is
achieved, pregnancy-related risks for the woman and
baby, and general health advice for the preconception
period.
App development working group
The app development working group included women
of childbearing age with T1DM and T2DM, age range
2243 years, with and without prior pregnancies. They
expressed desire for easily accessible and comprehen-
sive PCC information that was provided using positive
and supportive language.
Both groups were of the opinion that the informa-
tion should extend beyond preconception to include
diabetes and pregnancy, particularly what to expect
during pregnancy and delivery. They suggested includ-
ing a blood glucose diary, reminder and graph to help
women track and visualise their blood glucose levels in
the run up to pregnancy, and wanted a PCC app that
was attractive, simple and user friendly.
PADI app design and prototype development. The app
design was discussed with the app developer
(Netsells), which then created wireframes, a visual
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guide representing the skeletal framework of the app.
The wireframes were used to detail the app layout,
prioritise components and determine how the app
screens will link together. They took into account the
functionality of the screen, content, layout, app behav-
iour and sequencing of the app’s function. The output
of the wireframe work was then used to create an initial
prototype, a design model of the ﬁnal user interface
(UI), which gave the ﬁrst detailed impression of how
the UI or app screens would look and work. The app
prototype was designed to provide a series of informa-
tional pages and a place to submit and view blood glu-
cose readings by day, week and month. This initial
design output, however, highlighted potential usability
issues regarding the layout, colours and navigation.
The prototype was then revised several times to
ensure that the ﬁnal UI was simple, user friendly and
attractive.
PADI was developed both in Swift (programming
language for iOS) and Java (android development lan-
guage) in order to run both on Apple’s iOS and
Google’s Android platforms. An application program-
ming interface (API) was also developed to allow the
storage and retrieval of individual records of informa-
tion. The API routine connects PADI to Netsells’
remote server and along with the creation of user
accounts, allows authentication with the data in the
database. The API was developed using one of the
most popular programming languages for web applica-
tion backend development, Hypertext Preprocessor
(PHP) framework Laravel.41 The resulting prototype
was tested by Netsells in-house to ensure optimal func-
tionality before being released for further testing. The
ﬁnal prototype was presented to a selection of partici-
pants (healthcare professionals, women with DM,
researchers and members of the public) to test the full
 
Women
PADI app prototype 
Developer HCPs 
Piloting / testing with 
 
 
HCPs Women Public Researchers 
Consensus 
Yes No 
Final development and 
trial of app with  
women  
Figure 2. Diagrammatic representation of PADI app development process.
PADI: Preconception and Diabetes Information; HCPs: healthcare providers.
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app functionality for a period of 14 days and provide
feedback. The piloting comprised two cycles of
feedback and resulted in minor textual changes, modi-
ﬁcation of the blood glucose diary, and rectiﬁcation of
an error with the graphical display of blood glucose
readings. This process was deemed complete when the
modiﬁcations made were tested by participants and
their needs satisﬁed.
Features of the final PADI app. Screenshots of the ﬁnal app
(Figure 3) show the following features: Planning for
pregnancy and blood glucose diary with graphical dis-
play and reminder. The core aspects of these features
and their purpose within the app are shown in Table 2.
Outcome measures
As a feasibility study evaluating the process and/
acceptability of the intervention to users there is no
primary outcome measure.45,46 The study will explore
women’s satisfaction and experiences of using the
PADI app, and provide preliminary outcome estimates,
i.e. knowledge of preconception care, patient activation
measure (PAM) and attitudinal change to PCC.
Evaluative semi-structured interviews and log of activ-
ity after the three months of app use will seek to explore
perceived acceptability, utility and usability of the app.
Data collection
Background information. Information will be collected on
participants’ demographics and baseline characteristics.
A section containing questions aimed at capturing these
background data will be included in the patient
questionnaires (Q1) administered on enrolment.
Patient questionnaires. These will be administered at two
time points, on enrolment (at baseline) and following
Figure 3. Screenshots of the final Preconception and Diabetes Information (PADI) app.
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three months of PADI app usage, and will be informed
by previously validated tools involving PAM,47,48
reproductive health and diabetes instrument
(RHAB)49 and knowledge of PCC.21 These evaluative
questionnaires will be used to compare PAM, know-
ledge and attitudes to PCC before (pre-) and after
(post)-intervention. At the end of the study, partici-
pants will be required to repeat the initial questionnaire
(but without background information) (Q2).
Software log of activity. This will provide information on
the frequency of use of the app for accessing informa-
tional pages and for self-monitoring activities, i.e. log-
ging of blood glucose. This will be used to demonstrate
uptake/utilisation of PADI’s features. PADI has inbuilt
analytics that support collection of these data, which
will be stored on a secure server accessible only to
the app development company who will then ensure
secure transfer to the researcher (CHN) to allow data
analysis.
Patient interviews. Semi-structured face-to-face or tele-
phone interviews will be undertaken at the end of the
study, 4060 minutes with the ﬁrst six to eight partici-
pants30 from the intervention who consent to being
interviewed. Interviews will explore their experience of
using PADI and from this, common themes will be
identiﬁed regarding acceptability, impediments to regu-
lar usage and suggestions for improvement.40 The inter-
view schedule (Appendix) was informed by previously
published protocols for exploring participant experi-
ence of using an app.50
Table 2. Preconception and Diabetes Information (PADI) app feature description.
Features Aspects of the feature Purpose
Planning for pregnancy drafted in
line with National Institute for
Clinical Excellence (NICE) pre-
conception care (PCC)
guidelines3
This feature comprises 13 sections with information
on the various aspects of preparing for pregnancy
and what to expect during pregnancy and deliv-
ery. In addition to textual information, it contains
videos and uniform resource locators (URLs) that
users can click on to view more information on a
specific topic. These URLs take users out of the app
and to reliable external websites such as Diabetes
UK,42 NICE guidelines,3 Family Planning
Association (FPA)43 and womenwithdiabetes.-
net.21,44 PADI app icon will remain at the top of the
page and users can use this to navigate back to
their current session in the app.
Promote knowledge of PCC and pregnancy
planning.
Blood glucose diary (repre-
sented both in text format and
through data visualisation)
Blood glucose (BG) readings throughout the day are
recorded. Frequency depends on number of times
BG reading is taken and as advised by a health-
care professional. Users are able to select the
current time of day from a drop-down menu, e.g.
before breakfast. The time of reading is automat-
ically set and users have the option of being
reminded to take their next reading before saving
the BG reading. The list of entries is then dis-
played starting with the oldest to the most recent.
To record and keep track of BG reading.
Reminders These are set when a new reading is added. A noti-
fication is sent to the user’s phone at their set
reminder time. Users have the option to deactivate
set reminders by toggling the switch.
Reminder to take BG reading and help keep a
regular BG reading schedule.
Progress The inputted BG information is further broken
down into daily averages and represented in a
graph. BG readings outside recommended PCC
target range (49 mmol/l) trigger a pop-up fea-
ture and highlights the reading. Clicking on the
pop-up redirects users to the BG management
page within the app. Users can choose how they
want their progress displayed, e.g. today, past
seven days or 30 days.
To display the user’s progress and help monitor
trends.
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Data management and analysis
Microsoft Excel will be used for the organisation, col-
lation and recording of the quantitative data from each
participant. Processing of the questionnaire will be con-
sistent and a clear record of the returned questionnaires
will be kept. Each participant will be assigned a number
and the same number will be used throughout the study
to allow the data on demographic information, know-
ledge and attitudes to PCC and PAM to be correlated.
A coding manual will be developed for each question-
naire and used during the data entry process. The
responses will be assigned numerical codes and rec-
orded in the codebook. The data will then be entered
into Excel spreadsheets and later imported into SPSS
version 22 for analysis. Descriptive statistics will pro-
vide preliminary estimates of key parameters, as recom-
mended for feasibility studies.45,46
Content data from the open questions will be coded
by assigning data to categories and then labelling the
categories. Qualitative data (interviews) will be analysed
using inductive thematic analysis.51 Interviews will be
recorded, transcribed verbatim, and anonymised. QSR
Nvivo 1052 will be used as a data handling management
system for the data collected from the interviews. Nvivo
will be used mainly for the advantages it oﬀers in allow-
ing large volumes of data to be handled with speed,
preparing conceptual maps of coded data, facilitating
exploration of relationships between codes, and aiding
interpretation and theorising.33,51,52
Discussion
This paper presents a mixed-methods protocol that is
designed to examine the acceptability and feasibility of
the PADI app intervention. PADI incorporates both
PCC information and self-monitoring of blood glucose
(SMBG) functions. PCC education has been widely
recommended as an eﬀective strategy to promote
PCC knowledge and encourage behaviour
change.3,6,13,14,18,53 SMBG is a vital part of managing
glycaemic control and optimised glycaemic control is a
core component of PCC. Mobile phones have been
shown to improve glycaemic control in patients with
DM5456 and the eﬀectiveness of technological innov-
ations in improving PCC knowledge and attitude have
been demonstrated.1922 PADI is designed to improve
awareness of PCC and to support women with T1DM
and T2DM adopt behaviours that support a healthy
pregnancy and baby such as regular blood glucose
monitoring, folic acid intake, lifestyle modiﬁcation
and use of contraception until optimum blood glucose
levels are achieved.
Health interventions utilising mobile technologies
oﬀer many advantages including the potential for
wide-scale implementation and dissemination.40 They
are also able to penetrate disadvantaged or resource-
poor settings including developing countries, thereby
expanding the reach of health information to under-
served communities in line with the United Nations
sustainable development goals.57,58 Successful imple-
mentation of a technological innovation, however,
requires careful consideration of several factors.
For example, an intervention that is perceived as pro-
viding limited beneﬁts, diﬃcult to understand or ﬁt into
normal everyday practice would not appeal to health-
care professionals or policy makers.34,40 In order to
maximise beneﬁt, it is important for technological
interventions to be accepted by the target population
and normalised into practice.34,40 While a healthcare
professional may recommend a smartphone app, it is
ultimately up to those concerned to determine if the
app is beneﬁcial and worth an investment of their
time.59 Therefore, to increase PADI’s potential for
wide-scale adoption and implementation, women with
DM and their healthcare providers were involved in its
design and development, and the NPT framework34
was used to optimise the app development and inform
the study design.
This is the ﬁrst study to test the feasibility of a pre-
conception app speciﬁcally developed for women with
DM. Findings of the study will enhance understanding
of the role of apps in PCC of women with DM and
provide insight into their use for promoting PCC
awareness and behaviour change. It is anticipated
that PADI will provide an innovative way of providing
more women with DM with information on PCC. This
is important given the barriers associated with trad-
itional PCC practice8,12,15,17 and the limited technology
that is available to support PCC services.10 Given these
limitations, the PADI app has been designed both for
Apple iOS and Google Android, the two leading mobile
operating systems.60 If this study is successful, it will
provide the platform for a larger study to evaluate a
potentially feasible and easy-to-implement intervention
that can be integrated into healthcare and provide evi-
dence of its eﬀect on patient outcomes. However, for
this study participants will be required to download the
app onto their own phones and need to own a smart-
phone to be eligible to participate. Repeated examin-
ation of preliminary outcomes within three months may
introduce some information bias into the study. Also,
being a feasibility study, the sample size for the quan-
titative phase is quite small, limiting the generalisability
of the study ﬁndings to other contexts and populations.
Conclusion
The prevalence of DM in women of reproductive age is
growing, and improved PCC awareness is urgently
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required to reduce poor maternal and perinatal out-
comes experienced by women with DM, particularly
in low and middle income countries. Mobile technol-
ogy, mainly smartphones and apps, have the potential
to improve PCC and obstetric outcomes for women
with DM around the world, but, research is lacking
in this area. This is the ﬁrst study to explore the accept-
ability and feasibility of a preconception app for
women with DM, and the ﬁndings will inform the
development of a larger study. PADI could be easily
integrated into healthcare, scaled up and adapted into a
sustainable PCC intervention programme which could
be widely implemented, particularly in developing
countries where women have the highest risk of adverse
pregnancy outcomes. This is important given the con-
siderable shortfalls in current PCC provision around
the world and in the United Kingdom.
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Appendix
Semi-structured interview guide
1. Experience of using the smartphone App
How did you get on with using the App over the
last 3 months?
How did you ﬁnd navigating the pages and ﬁnding
information?
Did you have any problems using the app?
If you had problems, what were they?
Was the app easy to use?
2. Use of App for preconception care (PCC)
How did you ﬁnd using an App for PCC?
Did you use the app regularly e.g. 5 minutes/day?
 If no, why not.
How did you ﬁnd the information on preconcep-
tion care (PCC)?
Did you think the links to websites and videos were
helpful?
Did you use any other PCC services whilst in the
study (e.g. GP, other website)?
Is there any other information that you would have
liked included in the App?
3. Acceptability of features provided
What do you think of the blood glucose diary?
How did you ﬁnd inputting blood glucose data?
Did you use the reminders to record your blood
glucose reading?
 If no, why not.
 If yes, were the reminders helpful?
Did you use the progress feature to monitor
trends?
 If no, why not.
 If yes, did it help you in your diabetes
management?
What features did you ﬁnd useful?
Why did you ﬁnd these features useful?
4. Satisfaction with the app
What do you think about the overall content and
functionality of the App?
What did you like about having the PCC informa-
tion delivered via an app?
What did you dislike about having the PCC infor-
mation delivered via an app?
5. Feedback
What improvements can be made to the App?
Do you think any features could be removed or
added to the app?
Is there anything you would do diﬀerently follow-
ing your participation in the study?
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